(Reuters) – Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German partner BioNTech.
The company said it expects total 2021 revenue of between $59.4 billion and $61.4 billion.
(Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)
